Year None202420232022202120202019201820172016 April 26, 2024 Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management Go to April 24, 2024 Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting Go to April 9, 2024 Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) Go to April 9, 2024 Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) Go to April 4, 2024 Medicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Go to March 6, 2024 Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting Go to Pagination Current page 1 Page 2 Next page next › Last page last »
April 26, 2024 Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management Go to
April 24, 2024 Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting Go to
April 9, 2024 Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) Go to
April 9, 2024 Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR) Go to
April 4, 2024 Medicenna to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Go to
March 6, 2024 Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting Go to